论文部分内容阅读
目的通过使用再次经尿道膀胱肿瘤电切术治疗非肌层浸润性膀胱癌患者,观察分析其临床疗效及复发情况。方法采用随机数字表法将86例非肌层浸润性膀胱癌患者分为观察组与对照组,对照组给予单次经尿道膀胱肿瘤电切术,观察组在首次手术后2~6周再次给予经尿道膀胱肿瘤电切术;观察两组患者的临床疗效及复发情况,评价两种术式的疗效。结果观察组总缓解率为86.05%明显高于对照组的65.12%,差异有统计学意义(P<0.05);观察组复发率为2 0.93%、进展率为4.65%、死亡率为2.3 3%均低于对照组为44.19%、16.2 7%、11.63%,差异有统计学意义(P<0.05)。结论再次经尿道膀胱肿瘤电切治疗非肌层浸润性膀胱癌患者,较单次手术临床疗效好,复发率低,值得临床推广。
Objective To observe the clinical efficacy and recurrence of non-muscle invasive bladder cancer by using transurethral resection of bladder tumor. Methods 86 patients with non-muscle invasive bladder cancer were divided into observation group and control group by random number table method. The control group was given a single transurethral resection of bladder tumor. The observation group was re-given 2 to 6 weeks after the first operation Transurethral resection of bladder tumor; observed the clinical efficacy and recurrence of two groups of patients, evaluate the efficacy of the two surgical procedures. Results The total remission rate in observation group was 86.05%, which was significantly higher than 65.12% in control group (P <0.05). The recurrence rate in observation group was 2.93%, the rate of progress was 4.65% and the mortality rate was 2.3% Were lower than the control group was 44.19%, 16.27%, 11.63%, the difference was statistically significant (P <0.05). Conclusion Transurethral transurethral resection of the bladder tumor in patients with non-muscle invasive bladder cancer, compared with single-surgery clinical efficacy, low recurrence rate, worthy of clinical promotion.